MPI-CBG - Max Planck Institute of Molecular Cell Biology and Genetics

MPI-CBG - Max Planck Institute of Molecular Cell Biology and Genetics

Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), established in 1998, is a prominent member of the Max Planck Society, Germany's leading research organization. With over 500 scientists from 50 nationalities, MPI-CBG pioneers basic research in understanding how cells form tissues and the molecular principles underlying morphogenesis. The institute's research programs span from molecular levels to entire organisms, aiming to link tissue-level organizational principles to molecular activity.

MPI-CBG's commitment to cutting-edge research is complemented by extensive investments in Services and Facilities, providing researchers shared access to sophisticated technologies. Moreover, the institute actively develops new technologies to support its research mission. Collaborating with the Technische Universität Dresden (TUD), MPI-CBG hosts the International Max Planck Research School for Cell, Developmental, and Systems Biology (IMPRS-CellDevoSys), a 4-year PhD Program nurturing cross-disciplinary talents in life sciences, integrating Biology, Physics, Chemistry, and Computer Science.

As an investor, Max Planck Institute of Molecular Cell Biology and Genetics presents a compelling opportunity in the biotechnology sector due to its pioneering research, diverse talent pool, and strong collaboration with leading academic institutions.